The post Crypto.com brings Morpho lending to Cronos for stablecoin yields appeared on BitcoinEthereumNews.com. Crypto.com users will soon be able to lend wrapped crypto assets and earn yield on stablecoins through Morpho, a decentralized finance (DeFi) lending protocol. According to a Thursday statement, Morpho will launch stablecoin lending markets on the Cronos blockchain, with the first vaults expected this year. The integration will allow users to deposit wrapped Ether (ETH) or Bitcoin (BTC) into Morpho vaults and borrow stablecoins against them to earn yield. Wrapped assets are tokens that represent another cryptocurrency on a different blockchain. On Cronos, wrapped tokens such as CDCETH and CDCBTC mirror ETH and BTC, allowing users to bring value into the network and access DeFi lending markets without leaving the chain. Merlin Egalite, co-founder of Morpho, told Cointelegraph the goal is to provide “a trusted user experience in the front, with DeFi infrastructure in the back.” The protocol will be integrated directly into the Crypto.com platforms, making its lending features accessible to the platform’s users. Total value locked on DeFi lending protocols. Source: DeFillama Morpho, which matches lenders and borrowers on top of platforms such as Aave and Compound, has become the second-largest DeFi lending protocol, with a total value locked of around $7.7 billion, according to DefiLlama.  Egalite also confirmed that the protocol will be accessible to US users. While the Genius Act prohibits stablecoin issuers from paying reserve yields directly to holders, “lending a stablecoin and earning yield is a separate activity, independent of the issuer, so the restriction does not apply,” he said. Related: Crypto bill, stablecoins, new ETPs to drive Q4 crypto returns Genius Act leaves questions around stablecoin yield The collaboration between Morphos and Crypto.com only came a few weeks after a similar integration between Morphos and the US crypto exchange Coinbase.   On Sept. 18, Coinbase announced it was integrating the Morpho lending protocol directly… The post Crypto.com brings Morpho lending to Cronos for stablecoin yields appeared on BitcoinEthereumNews.com. Crypto.com users will soon be able to lend wrapped crypto assets and earn yield on stablecoins through Morpho, a decentralized finance (DeFi) lending protocol. According to a Thursday statement, Morpho will launch stablecoin lending markets on the Cronos blockchain, with the first vaults expected this year. The integration will allow users to deposit wrapped Ether (ETH) or Bitcoin (BTC) into Morpho vaults and borrow stablecoins against them to earn yield. Wrapped assets are tokens that represent another cryptocurrency on a different blockchain. On Cronos, wrapped tokens such as CDCETH and CDCBTC mirror ETH and BTC, allowing users to bring value into the network and access DeFi lending markets without leaving the chain. Merlin Egalite, co-founder of Morpho, told Cointelegraph the goal is to provide “a trusted user experience in the front, with DeFi infrastructure in the back.” The protocol will be integrated directly into the Crypto.com platforms, making its lending features accessible to the platform’s users. Total value locked on DeFi lending protocols. Source: DeFillama Morpho, which matches lenders and borrowers on top of platforms such as Aave and Compound, has become the second-largest DeFi lending protocol, with a total value locked of around $7.7 billion, according to DefiLlama.  Egalite also confirmed that the protocol will be accessible to US users. While the Genius Act prohibits stablecoin issuers from paying reserve yields directly to holders, “lending a stablecoin and earning yield is a separate activity, independent of the issuer, so the restriction does not apply,” he said. Related: Crypto bill, stablecoins, new ETPs to drive Q4 crypto returns Genius Act leaves questions around stablecoin yield The collaboration between Morphos and Crypto.com only came a few weeks after a similar integration between Morphos and the US crypto exchange Coinbase.   On Sept. 18, Coinbase announced it was integrating the Morpho lending protocol directly…

Crypto.com brings Morpho lending to Cronos for stablecoin yields

Crypto.com users will soon be able to lend wrapped crypto assets and earn yield on stablecoins through Morpho, a decentralized finance (DeFi) lending protocol.

According to a Thursday statement, Morpho will launch stablecoin lending markets on the Cronos blockchain, with the first vaults expected this year. The integration will allow users to deposit wrapped Ether (ETH) or Bitcoin (BTC) into Morpho vaults and borrow stablecoins against them to earn yield.

Wrapped assets are tokens that represent another cryptocurrency on a different blockchain. On Cronos, wrapped tokens such as CDCETH and CDCBTC mirror ETH and BTC, allowing users to bring value into the network and access DeFi lending markets without leaving the chain.

Merlin Egalite, co-founder of Morpho, told Cointelegraph the goal is to provide “a trusted user experience in the front, with DeFi infrastructure in the back.” The protocol will be integrated directly into the Crypto.com platforms, making its lending features accessible to the platform’s users.

Total value locked on DeFi lending protocols. Source: DeFillama

Morpho, which matches lenders and borrowers on top of platforms such as Aave and Compound, has become the second-largest DeFi lending protocol, with a total value locked of around $7.7 billion, according to DefiLlama. 

Egalite also confirmed that the protocol will be accessible to US users. While the Genius Act prohibits stablecoin issuers from paying reserve yields directly to holders, “lending a stablecoin and earning yield is a separate activity, independent of the issuer, so the restriction does not apply,” he said.

Related: Crypto bill, stablecoins, new ETPs to drive Q4 crypto returns

Genius Act leaves questions around stablecoin yield

The collaboration between Morphos and Crypto.com only came a few weeks after a similar integration between Morphos and the US crypto exchange Coinbase.  

On Sept. 18, Coinbase announced it was integrating the Morpho lending protocol directly into its app with vaults managed by DeFi advisory company Steakhouse Financial. Like the Crypto.com integration, the feature lets users lend the USDC (USDC) without leaving the platform for external DeFi services or wallets.

According to Coinbase, the new integration will enable users to access onchain lending markets and potentially earn yields of up to 10.8%, significantly higher than the current 4.5% APY in rewards given for holding USDC on the platform.

A few days later, the CEO of Coinbase, Brian Armstrong, said the company aims to become a full-service crypto “super app,” and ultimately replace people’s need for traditional banks.

Unsurprisingly, banks are pushing back. In August, the Bank Policy Institute (BPI) and several US financial institutions wrote a letter to the US Congress urging them to close stablecoin loopholes that they claim allow stablecoin issuers to compete with banks without equivalent oversight. According to the letter, failing to do so could drain as much as $6.6 trillion in deposits from the US banking system.

On Sept. 16, Coinbase called the banks’ allegations false in a blog post, stating there is no evidence that stablecoin growth has caused deposit outflows at local banks. The post said:

Although the Genius Act, which was signed into law in the US in July 2025, banned interest-bearing stablecoins, it does not explicitly prevent crypto exchanges or affiliated businesses from providing yield.

Magazine: The one thing these 6 global crypto hubs all have in common…

Source: https://cointelegraph.com/news/crypto-com-morpho-lending-stablecoin-yield-cronos?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Market Opportunity
MORPHO Logo
MORPHO Price(MORPHO)
$1.133
$1.133$1.133
-0.31%
USD
MORPHO (MORPHO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26